STA
EBS icon

Summit Trail Advisors’s Emergent Biosolutions EBS Stock Holding History

Summit Trail Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,066
Closed -$728K – 154
2018
Q3 		$728K Buy
11,066
+2,613
+31% +$152K 0.16% 74
2018
Q2 		$427K Sell
8,453
-28,068
-77% -$1.46M 0.15% 79
2018
Q1 		$1.38M Buy
36,521
+3,637
+11% +$181K 0.23% 96
2017
Q4 		$1.63M Buy
+32,884
New +$1.38M 0.21% 92

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Summit Trail Advisors's EBS Position: Q4 2018 in Review

Summit Trail Advisors sold out of Emergent Biosolutions (EBS) in Q4 2018, closing a stake of 11,066 shares — an estimated $728K sold.

Summit Trail Advisors first reported a position in EBS in Q4 2017 and held it in 4 quarters. The position peaked at $1.63M in Q4 2017. 297 funds tracked by Wall St. Rank hold EBS as of Q4 2018.

  • Summit Trail Advisors reported no remaining Emergent Biosolutions position as of Q4 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 11,066 Emergent Biosolutions shares in Q4 2018, an estimated $728K.
  • Summit Trail Advisors first reported a position in Emergent Biosolutions in Q4 2017 and held it in 4 quarters.
  • Summit Trail Advisors's Emergent Biosolutions position peaked at $1.63M in Q4 2017.
  • 297 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2018.

Based on Summit Trail Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.